GlassScriptPrepare for your visit
Sandra Manssur
Family · Flint, MI · NPI 1336252329
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$3,153.14
in general payments reported to CMS, 2019-2025 · $232 in 2025
The $232 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Who reported paying
General payments only, top 6 by amount.
- Viiv Healthcare Company $1,045.19
- Gilead Sciences, INC. $643.26
- Abbvie INC. $280.73
- Theratechnologies INC. $173.76
- Merck Sharp & Dohme LLC $168.28
- Janssen Biotech, INC. $166.27
Drugs and devices associated with these payments
Journavx Sunlenca Vraylar Rezdiffra Abilify Maintena Abilify Asimtufii Mavyret Descovy Epclusa Perseris Symtuza Flucelvax Quadrivalent
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Sandra Manssur listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/10745767/sandra-manssur